Clinical Trial Update: Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety and tolerability of oral clofarabine in intermediate to high-risk myelodysplastic syndrome; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Myelodysplastic Syndrome | Phase 1 | Status: TERMINATED